2024
Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study
Hill K, Minahan-Rowley R, Biegacki E, Heimer R, Sue K. Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study. Harm Reduction Journal 2024, 21: 148. PMID: 39148036, PMCID: PMC11328386, DOI: 10.1186/s12954-024-01052-4.Peer-Reviewed Original ResearchConceptsSequential explanatory mixed-methods studyExplanatory mixed-methods studyMixed-methods studyHealthcare providersHealthcare providers' experiencesHealthcare providers treating patientsSample of providersProviders treating patientsDrug supplyProvider experienceProvider knowledgeIn-depth interviewsImprove careSense of helplessnessConvenience sampleHealthcare educationThematic analysisInterview transcriptsQualitative phasePurposive samplingProvidersHealthcareOpioid supplyAbsence of literatureResultsSeventy-eightDrawing on Black and Queer Communities' Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.
Johnson S, Sue K. Drawing on Black and Queer Communities' Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies. The AMA Journal Of Ethic 2024, 26: e580-586. PMID: 38958427, DOI: 10.1001/amajethics.2024.580.Peer-Reviewed Original Research
2023
Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study
Chayama K, Ng C, Fleming T, Small W, Sue K, McNeil R. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study. Harm Reduction Journal 2023, 20: 126. PMID: 37679789, PMCID: PMC10483728, DOI: 10.1186/s12954-023-00862-2.Peer-Reviewed Original ResearchConceptsSyringe services programSyringe distribution programsInjecting equipmentSingle room occupancy hotelsDrug-related risksDistribution programHarm reduction measuresHarm reduction supportsLow-threshold accessMethodsBetween JanuaryPWIDDrug useSyringe possessionPeer staffMost participantsIllicit drugsDrugsService programsSyringesSupportive housingParticipantsImproving the Health of People Who Inject Drugs Through COVID-19–Related Policies
Hill K, Thakarar K, Eslinger H, Prosperino L, Sue K. Improving the Health of People Who Inject Drugs Through COVID-19–Related Policies. Public Health Reports 2023, 138: 862-864. PMID: 37610106, PMCID: PMC10576482, DOI: 10.1177/00333549231192468.Commentaries, Editorials and LettersRecognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut
Dowton A, Doernberg M, Heiman E, Barelli P, Golden M, Wang H, Leventhal J, Morford K, Sue K. Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut. Journal Of Addiction Medicine 2023, 17: 739-741. PMID: 37934550, DOI: 10.1097/adm.0000000000001198.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersDrug useCase report presentsIndex of suspicionInjection drug useDrug supplyCare management strategiesHarm reduction strategiesOverdose presentationsCutaneous manifestationsWithdrawal syndromeClinical complicationsCase reportIntravenous useWound carePatientsTreatment of woundsInfectious diseasesChronic woundsXylazineSkin woundsWoundsMore reportingDiagnosisChanging approaches to treating opioid withdrawal in the USA
Hughes M, Edinoff A, Sue K. Changing approaches to treating opioid withdrawal in the USA. The Lancet Psychiatry 2023, 10: 378-380. PMID: 37167986, DOI: 10.1016/s2215-0366(23)00145-1.Commentaries, Editorials and LettersPerspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs
Sue K, Chawarski M, Curry L, McNeil R, Coupet E, Schwartz R, Wilder C, Tsui J, Hawk K, D’Onofrio G, O’Connor P, Fiellin D, Edelman E. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs. JAMA Network Open 2023, 6: e2312718. PMID: 37163263, PMCID: PMC10173026, DOI: 10.1001/jamanetworkopen.2023.12718.Peer-Reviewed Original ResearchConceptsCommunity-based cliniciansOpioid use disorderEmergency departmentOUD treatmentMedication treatmentSubstance use disorders trainingUrban academic emergency departmentEffectiveness-implementation studyAcademic emergency departmentDisorder treatment settingsPerspectives of cliniciansCommunity-based treatmentCommunity-based treatment programsStaff perspectivesImplementation science frameworkBuprenorphine programTreatment cliniciansPeer navigatorsReferral sitesPromoting ActionMAIN OUTCOMEED staffBuprenorphineFocus groupsUse disorders
2022
Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection
Rosen J, Glick J, Zhang L, Cooper L, Olatunde P, Pelaez D, Rouhani S, Sue K, Park J. Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection. Addiction 2022, 118: 847-854. PMID: 36468191, PMCID: PMC10073256, DOI: 10.1111/add.16103.Peer-Reviewed Original ResearchConceptsThreat of violenceCross-sectional qualitative studyDepth interviewsHarm reduction strategiesPublic spaceOverdose riskDrug useThematic analysisQualitative studyEmergent designSocial environmentRisk environmentNaloxone possessionBaltimore CityInterviewsWWIDReduction strategiesOpioid withdrawalViolenceFatal overdoseStreet interceptXylazine and Overdoses: Trends, Concerns, and Recommendations.
Alexander RS, Canver BR, Sue KL, Morford KL. Xylazine and Overdoses: Trends, Concerns, and Recommendations. American Journal Of Public Health 2022, 112: 1212-1216. PMID: 35830662, PMCID: PMC9342814, DOI: 10.2105/ajph.2022.306881.Peer-Reviewed Original ResearchConceptsIllicit drug supplyDrug supplyNovel treatment strategiesPublic health interventionsPublic health systemHarm reduction strategiesTreatment strategiesOverdose deathsHealth interventionsStriking prevalenceHealth systemXylazineExposure levelsPrevalencePotential riskPotential toxicityOpioidsOverdosesThe practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids
Ivsins A, Fleming T, Barker A, Mansoor M, Thakarar K, Sue K, McNeil R. The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids. International Journal Of Drug Policy 2022, 107: 103791. PMID: 35830749, PMCID: PMC10894463, DOI: 10.1016/j.drugpo.2022.103791.Peer-Reviewed Original ResearchConceptsDowntown Eastside neighbourhoodDrug use practicesQualitative studyLittle qualitative researchUse practicesRole of pleasureDepth interviewsQualitative datasetQualitative researchEmbodied experienceDistinct practicesPolysubstance useEffects of opioidsInterviewsPracticeEffects of methamphetamineExperienceSupply interventionsImportant gapOpioidsStimulant useDrugsInitiativesMethamphetamineVancouverUsing a structural vulnerability framework to understand the impact of COVID‐19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City
Zhen‐Duan J, Gade N, Falgas‐Bagué I, Sue KL, DeJonckheere M, Alegría M. Using a structural vulnerability framework to understand the impact of COVID‐19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City. Health Services Research 2022, 57: 1104-1111. PMID: 35340033, PMCID: PMC9111318, DOI: 10.1111/1475-6773.13975.Peer-Reviewed Original ResearchConceptsNew York CityLow-income individualsStructural vulnerabilityPrimary qualitative dataDepth qualitative interviewsQualitative research approachCOVID-19 pandemicThematic analysis approachYork CityDepth interviewsEconomic disparitiesQualitative interviewsVulnerability frameworkEthnic minority adultsFood insecurityStructural competencyQualitative dataSocial relationshipsHousing conditionsThematic analysisCommunity resourcesResearch approachCOVID-19Theoretical frameworkHome ordersCharacterizing stimulant overdose: A qualitative study on perceptions and experiences of “overamping”
Mansoor M, McNeil R, Fleming T, Barker A, Vakharia S, Sue K, Ivsins A. Characterizing stimulant overdose: A qualitative study on perceptions and experiences of “overamping”. International Journal Of Drug Policy 2022, 102: 103592. PMID: 35114520, PMCID: PMC9381030, DOI: 10.1016/j.drugpo.2022.103592.Peer-Reviewed Original ResearchConceptsDowntown Eastside neighbourhoodCurrent overdose crisisOverdose crisisNorth America's overdose crisisDepth qualitative interviewsStimulant overdosesHarm reduction campaignsOpioid-related overdose risksQualitative interviewsDominant focusHarm reduction effortsThematic analysisQualitative studyHarm reduction interventionsReduction campaignsRole of stimulantsIndividual experiencesLess attentionReduction effortsCrisisInterviewsExperiencePublic healthOverdose riskReduction interventionsA Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era
Sue KL, Cohen S, Tilley J, Yocheved A. A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era. Journal Of Addiction Medicine 2022, 16: 389-391. PMID: 35020693, DOI: 10.1097/adm.0000000000000952.Commentaries, Editorials and LettersHarm Reduction in Health Care Settings
Chan CA, Canver B, McNeil R, Sue KL. Harm Reduction in Health Care Settings. Medical Clinics Of North America 2022, 106: 201-217. PMID: 34823731, DOI: 10.1016/j.mcna.2021.09.002.Peer-Reviewed Original ResearchMeSH KeywordsAlcohol DrinkingAnalgesics, OpioidBehavior, AddictiveCentral Nervous System StimulantsCounselingDelivery of Health CareDrug OverdoseFentanylHarm ReductionHumansInfection ControlMaleNaloxoneNarcotic AntagonistsNarcoticsOpioid-Related DisordersPre-Exposure ProphylaxisSubstance-Related Disorders
2021
Black Pain Matters: Prioritizing Antiracism and Equity in the Opioid Epidemic
Essien UR, Ifidon A, Sue KL. Black Pain Matters: Prioritizing Antiracism and Equity in the Opioid Epidemic. Journal Of Hospital Medicine 2021, 16: 638-639. PMID: 34613902, PMCID: PMC8494278, DOI: 10.12788/jhm.3703.Commentaries, Editorials and LettersBringing Harm Reduction into Health Policy — Combating the Overdose Crisis
Sue KL, Fiellin DA. Bringing Harm Reduction into Health Policy — Combating the Overdose Crisis. New England Journal Of Medicine 2021, 384: 1781-1783. PMID: 33983692, DOI: 10.1056/nejmp2103274.Commentaries, Editorials and Letters
2019
Smoking and hospitalisation: harnessing medical ethics and harm reduction
Sue K, Applewhite D. Smoking and hospitalisation: harnessing medical ethics and harm reduction. Journal Of Medical Ethics 2019, 45: 483. PMID: 30846491, DOI: 10.1136/medethics-2018-105065.Peer-Reviewed Original Research